ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

0.000001 0 (0%)  11-13 12:25
Open: 0 Prev Close: 0.000001
High: 0 Low: 0
Volume: 0 Market Cap: 0M
Year High: 0.17 Year Low: 0
Stock Technical Analysis
Targets Six months: 0.1011    One year: 0.1635
Supports Support1:    Support2:
Resistances Resistance1: 0.0865    Resistance2: 0.1400 
Pivot Point 0.0953 
Moving Averages MA(5): 0.0660      MA(20): 0.0995 

MA(100): 0.1179  -1     MA(250):  
MACD MACD(12,26): -0.018      Signal(12,26,9): -0.008 
Stochastic Oscillator %K(14,3): 0.037      %D(3):  
RSI RSI(14): 6.725 
52-Week High: 0.2100  Low:   Change(%): -100
Average Volume(K) 3-Month: 153  10-Days: 0
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed below its lower band by 13.8%; Bollinger Bands are 298% wider than normal.The large width of the bands suggest high volatility as compared to VGEN's normal range. The bands have been in this wide range for 1 bars. This is often a sign that the current trend may be ending.


Stock Chart

Top 100 stocks

Stock News
Vaccinogen Announces Filing of Oncavert® Patent Application
Thu, 16 Jun 2016 15:22:30 GMT

Vaccinogen Enhances Patient-Derived Antibody Program with Revolutionary High ...
Wed, 09 Sep 2015 11:34:35 GMT

Vaccinogen Completes Initial Closing of an $80 Million Financing
Mon, 25 Aug 2014 10:52:30 GMT

Vaccinogen Engages D. Barry Boyd, MD, MS, as Senior Oncology Advisor
Wed, 28 Oct 2015 11:46:40 GMT

Ben Carson steps down from Vaccinogen role, citing presidential campaign
Tue, 05 May 2015 21:50:15 GMT

Vaccinogen Inc. (OTCMKTS:VGEN) is Attracting Smart Money
Mon, 13 Feb 2017 19:44:30 GMT

Carson's cash: Highly conservative interests have fueled his campaign and kept ...
Tue, 06 Dec 2016 19:24:53 GMT

US company signs option with DCU on cancer treatment
Mon, 23 Nov 2015 08:03:45 GMT

Dr. Ben Carson joins board of HomeCentris Healthcare
Mon, 23 Mar 2015 21:12:44 GMT

Global Cancer Immunotherapy Market Analysis & Forecast to 2022 - Research and ...
Thu, 26 Oct 2017 10:05:30 GMT